University of Naples Federico II-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Supportive oncodermatology practices in Europe and the USA

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Clinical characterization and treatment outcomes of follicular cutaneous immune–related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study

    Journal of the American Academy of Dermatology, Vol. 88, Núm. 3, pp. 718-720

  2. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study

    Cancers, Vol. 15, Núm. 14

2022

  1. Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*

    British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969

  2. European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

    Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 3, pp. 332-350

2019

  1. Assessment of Quality of Life and Treatment Outcomes of Patients with Persistent Postchemotherapy Alopecia

    JAMA Dermatology, Vol. 155, Núm. 6, pp. 724-728

  2. Clinical Characterization of Immunotherapy-Related Pruritus among Patients Seen in 2 Oncodermatology Clinics

    JAMA Dermatology

  3. Treatment outcomes of immune-related cutaneous adverse events

    Journal of Clinical Oncology, Vol. 37, Núm. 30, pp. 2746-2758